Actavis Pharmaceuticals recalls buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Dis
Recalled March 6, 2013 · FDA recall D-175-2013 · Actavis Pharmaceuticals
Hazard
Failed Dissolution Specifications; 8-hours for the 18-month stability testing point. · FDA Class III
Units
14,856 bottles
Sold at
Nationwide
Description
Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.
Product
buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217
Manufacturer(s)
Actavis Pharmaceuticals
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →